HT
LABD icon

Headlands Technologies’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Headlands Technologies’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,395
Closed -$414K – 1381
2025
Q1 		$414K Sell
4,395
-1,398
-24% -$102K 0.05% 320
2024
Q4 		$420K Buy
+5,793
New +$354K 0.04% 371
2024
Q2 		– Sell
-2,836
Closed -$207K – 1398
2024
Q1 		$207K Buy
2,836
+1,608
+131% +$134K 0.05% 365
2023
Q4 		$119K Buy
1,228
+386
+46% +$75.1K 0.04% 359
2023
Q3 		$173K Buy
+842
New +$137K 0.09% 222

Other funds holding LABD

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Headlands Technologies's LABD Position: Q2 2025 in Review

Headlands Technologies sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2025, closing a stake of 4,395 shares — an estimated $414K sold.

Headlands Technologies first reported a position in LABD in Q3 2023 and held it in 5 quarters. The position peaked at $420K in Q4 2024. 18 funds tracked by Wall St. Rank hold LABD as of Q2 2025.

  • Headlands Technologies reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q2 2025 after selling out during the quarter.
  • Headlands Technologies sold 4,395 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2025, an estimated $414K.
  • Headlands Technologies first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2023 and held it in 5 quarters.
  • Headlands Technologies's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $420K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2025.

Based on Headlands Technologies's 13F filing for Q2 2025, filed 14 Aug 2025.